Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy
Clinical trial NCT03140670 · TERMINATED
Trial details
- NCT number
- NCT03140670
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2020-10-29
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.